Refine
Has Fulltext
- yes (19)
Is part of the Bibliography
- yes (19)
Year of publication
Document Type
- Journal article (19)
Language
- English (19) (remove)
Keywords
- B cells (2)
- BMP (2)
- BMP-2 (2)
- Bone morphogenetic protein-2 (2)
- bone regeneration (2)
- gene expression (2)
- growth factor beta (2)
- multiple myeloma (2)
- subcutaneous animal model (2)
- tissue engineering (2)
- Apoptosis (1)
- B cell receptors (1)
- BMP-2 delivery (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Bone tissue engineering (1)
- CYR61 (1)
- Cancer (1)
- GDF-5 (1)
- Growth; BMP-2 (1)
- In-vitro (1)
- Mandibular continuity defects (1)
- Marrow stromal cells (1)
- Mechanisms (1)
- Mesenchymal transition (1)
- Microenvironment (1)
- Myofibroblast differentiation (1)
- Oral squamous cell carcinoma (1)
- Proliferation (1)
- R57A (1)
- Receptor (1)
- Sinus floor augmentation (1)
- Smooth-muscle-cells (1)
- Squamous-cell carcinoma (1)
- TGF-beta (1)
- TGFβ/BMP signaling (1)
- Tumorigenicity (1)
- animal model (1)
- antagonist (1)
- apoptosis (1)
- betaglycan (1)
- biocompatibility (1)
- biocompatible materials (1)
- bioconjugation (1)
- biological models (1)
- bone critical size defect (1)
- bone marrow (1)
- bone morphogenetic protein (1)
- bone morphogenetic protein 2 (BMP2) (1)
- bone morphogenetic protein 9 (BMP9) (1)
- bone morphogenetic proteins (1)
- brachtydacyly type A2 (1)
- cartilage (1)
- cell binding (1)
- cell cycle and cell division (1)
- cell differentiation (1)
- cell metabolism (1)
- cell proliferation (1)
- chondrogenesis (1)
- chondrogenic hypertrophy (1)
- clinical applications (1)
- collagen sponge (1)
- coreceptor (1)
- covalent coupling (1)
- cross-talk (1)
- cryostructured scaffolds (1)
- crystal structure (1)
- crystal-structure (1)
- differentiation (1)
- dominant-negative mutatio (1)
- fibroblast growth factor (1)
- functional initiators (1)
- gene encoding noggin (1)
- glycoprotein (1)
- growth and differentiation factor 5 (1)
- heparin binding sites (1)
- inflammation (1)
- interface (1)
- inflammatory response (1)
- iron metabolism (1)
- ligand binding (1)
- ligand-receptor complex (1)
- ligand-receptor promiscuity (1)
- membrane receptor signaling (1)
- mesenchymal stromal cell (1)
- metallo-supramolecular polymer (1)
- molecular mechanism (1)
- morphogenetic protein receptors (1)
- mutagenesis (1)
- necrotic cell death (1)
- osteochondral lesion (1)
- platelet-derived growth factor (1)
- polymerization (1)
- polypeptoids (1)
- postpolymerization modification (1)
- proteins (1)
- receptor type III (1)
- regenerative medicine (1)
- rhBMP–2 (1)
- ring-opening polymerization (1)
- signal integration (1)
- signal specification (1)
- signal tranduction (1)
- signal transduction (1)
- signaling (1)
- superfamily (1)
- translational research (1)
- weight-bearing (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (19)
- Julius-von-Sachs-Institut für Biowissenschaften (6)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (3)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (3)
- Institut für Funktionsmaterialien und Biofabrikation (2)
- Institut für Organische Chemie (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Augenklinik und Poliklinik (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 607051 (3)
- 242175-VascuBone (1)
- 242175‐VascuBone (1)
- 309962 (1)
- 723770 (1)
Growth and Differentiation Factor 5 (GDF5) is a secreted growth factor that belongs to the Bone Morphogenetic Protein (BMP) family and plays a pivotal role during limb development. GDF5 is a susceptibility gene for osteoarthritis (OA) and mutations in GDF5 are associated with a wide variety of skeletal malformations ranging from complex syndromes such as acromesomelic chondrodysplasias to isolated forms of brachydactylies or multiple synostoses syndrome 2 (SYNS2). Here, we report on a family with an autosomal dominant inherited combination of SYNS2 and additional brachydactyly type A1 (BDA1) caused by a single point mutation in GDF5 (p.W414R). Functional studies, including chondrogenesis assays with primary mesenchymal cells, luciferase reporter gene assays and Surface Plasmon Resonance analysis, of the GDF5 W-414R variant in comparison to other GDF5 mutations associated with isolated BDA1 (p.R399C) or SYNS2 (p.E491K) revealed a dual pathomechanism characterized by a gain-and loss-of-function at the same time. On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype. Whereas on the other hand, a reduced signaling activity, specifically via the BMP receptor type IA (BMPR1A), is likely responsible for the BDA1 phenotype. These results demonstrate that one mutation in the overlapping interface of antagonist and receptor binding site in GDF5 can lead to a GDF5 variant with pathophysiological relevance for both, BDA1 and SYNS2 development. Consequently, our study assembles another part of the molecular puzzle of how loss and gain of function mutations in GDF5 affect bone development in hands and feet resulting in specific types of brachydactyly and SYNS2. These novel insights into the biology of GDF5 might also provide further clues on the pathophysiology of OA.